Results 291 to 300 of about 2,712,589 (407)

Recent Advances in Cancer Cell Membrane‐Based Nanoparticles and Cancer Cell‐Derived Small Extracellular Vesicles as Drug Delivery Platforms

open access: yesAdvanced NanoBiomed Research, EarlyView.
Cancer cell membrane‐based nanoparticles (CCM‐NPs) and cancer cell‐derived small extracellular vesicles (CsEVs) are emerging as promising drug delivery systems for targeted cancer treatment. Advances in nanotechnology have paved the way for innovative drug delivery systems that enhance the effectiveness of cancer treatment.
Wei Zhang   +4 more
wiley   +1 more source

Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders. [PDF]

open access: yesMolecules, 2023
Francucci B   +9 more
europepmc   +1 more source

Evidence for deactivation of both ectosolic and cytosolic 5'-nucleotidase by adenosine A1 receptor activation in the rat cardiomyocytes. [PDF]

open access: bronze, 1994
Masafumi Kitakaze   +9 more
openalex   +1 more source

A randomized phase 1 study of safety, tolerability, and pharmacokinetics of MK-1088, a novel dual adenosine receptor antagonist, in healthy adult participants. [PDF]

open access: yesInvest New Drugs
Gupta P   +9 more
europepmc   +1 more source

Binding characteristics of an adenosine receptor in human placenta

open access: hybrid, 1985
Theodore A. Alston   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy